Kerstin G.
- Country
- Sweden
- Department
- Oncology (Jubileumskliniken)
Research Overview
Data & Insights
Has run more than one trial at 0 of 39 partner sites.
Specializations
Oncology Research
The investigator specializes in the treatment of advanced non-small cell lung cancer (NSCLC), with particular focus on locally advanced unresectable Stage III disease.
- Advanced lung cancer therapeutics
- Stage III NSCLC management
- Targeted therapy approaches
Key interests include novel therapeutic strategies for locally advanced lung cancer and innovative treatment combinations.
Treatment Modalities
Primary expertise centers on integrating various treatment approaches including chemoradiotherapy and targeted therapies for thoracic malignancies.
- Concurrent chemoradiotherapy (cCRT)
- Sequential chemoradiotherapy (sCRT)
- Combination therapy strategies
Focuses on optimizing treatment sequences and combinations for enhanced therapeutic outcomes.
Precision Medicine
Investigates biomarker-selected treatment approaches in thoracic oncology, emphasizing personalized therapeutic strategies.
- Biomarker analysis
- Patient-specific therapy selection
- Treatment response monitoring
Explores the role of molecular markers in guiding treatment decisions for lung cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.